Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2022 ∙ Lane, S. Yeomans, A. Shakir, S.
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature
Adolescents Adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Parker, E. P. K. Desai, S. Marti, M. Nohynek, H. Kaslow, D. C. Kochhar, S. O'Brien, K. L. Hombach, J. Wilder-Smith, A.
Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
Adults Older adults COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Kroon, F. P. B. Najm, A. Alunno, A. Schoones, J. W. Landewe, R. B. M. Machado, P. M. Navarro-Compan, V.
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations
All age groups COVID-19 Safety Efficacy/effectiveness
Rating:
Low
2022 ∙ Tsiorou, K. Sarantaki, A.
Risk Assessment of COVID-19 Vaccination Among Childbearing Women
Adults Adolescents Pregnant women COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Petrá M Janovská, D. Čelko, A. M. D Selinger, E. Dole Neradov Franklová, M. Dlouhý, P. Rosina, J. Lesná, I. K.
Risk factors affecting COVID-19 vaccine effectiveness identified from 290 cross-country observational studies until February 2022: a meta-analysis and meta-regression
All age groups COVID-19 Efficacy/effectiveness
Rating:
Low
2022 ∙ Dzinamarira, Tafadzwa Murewanhema, Grant Chitungo, Itai Ngara, Bernard Nkambule, Sphamandla Josias Madziva, Roda Herrera, Helena Mukwenha, Solomon Cuadros, Diego F. Iradukunda, Patrick Gad Mashora, Moreblessing Tungwarara, Nigel Rwibasira, Gallican Nshogoza Musuka, Godfrey
Risk of mortality in HIV-infected COVID-19 patients: A systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Flacco, M. E. Acuti Martellucci, C. Baccolini, V. De Vito, C. Renzi, E. Villari, P. Manzoli, L.
Risk of reinfection and disease after SARS-CoV-2 primary infection: meta-analysis
Adults Older adults Adolescents COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Chu, D. K. Abrams, E. M. Golden, D. B. K. Blumenthal, K. G. Wolfson, A. R. Stone, C. A., Jr. Krantz, M. S. Shaker, M. Greenhawt, M.
Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis
Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ SeyedAlinaghi, S. Karimi, A. Pashaei, Z. Afzalian, A. Mirzapour, P. Ghorbanzadeh, K. Ghasemzadeh, A. Dashti, M. Nazarian, N. Vahedi, F. Tantuoyir, M. M. Shamsabadi, A. Dadras, O. Mehraeen, E.
Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review
Adolescents Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Dadras, O. Mehraeen, E. Karimi, A. Tantuoyir, M. M. Afzalian, A. Nazarian, N. Mojdeganlou, H. Mirzapour, P. Shamsabadi, A. Dashti, M. Ghasemzadeh, A. Vahedi, F. Shobeiri, P. Pashaei, Z. SeyedAlinaghi, S.
Safety and Adverse Events Related to Inactivated COVID-19 Vaccines and Novavax;a Systematic Review
All age groups COVID-19 Safety
Rating:
Critically low
Loading...